What changed
No revenue yet — this is a development-stage story built on IP. NewHydrogen has filed multiple patents, including a first international PCT application jointly with UC Santa Barbara.
Risks are steep. Hydrogen equities like NEL ASA, ITM Power and McPhy have fallen sharply, and Thyssenkrupp's planned Nucera listing is cited as facing valuation headwinds on fragile sentiment.
The bull case rests on partnerships: collaborations exploring integration with NuCube Energy's NuSun small modular reactors and a site assessment at USREL's Orangeville, Utah facility. Commercialization, not revenue, is the milestone to watch.
Bottom line: a pre-revenue bet on thermochemical hydrogen IP in a sector investors have been punishing. The tech and partners are the entire story here — proceed accordingly.